Connect

Member Research and Reports

Member Research and Reports

UAB: Moderate Fixed‐Dose Hydroxyurea for Primary Prevention of Strokes in Nigerian Children With Sickle Cell Disease – Final Results of the SPIN Trial

Tags: ,